[New antibiotics - standstill or progress].
Rademacher, J
[New antibiotics - standstill or progress]. [electronic resource] - Medizinische Klinik, Intensivmedizin und Notfallmedizin Apr 2017 - 206-213 p. digital
Publication Type: Comparative Study; Journal Article; Review
2193-6226
10.1007/s00063-017-0271-3 doi
Anti-Bacterial Agents--adverse effects
Azabicyclo Compounds--therapeutic use
Bacterial Infections--drug therapy
Ceftazidime--therapeutic use
Cephalosporins--adverse effects
Clinical Trials as Topic
Drug Approval
Drug Combinations
Drug Resistance, Multiple, Bacterial
Ephedrine
Humans
Macrolides--adverse effects
Methicillin-Resistant Staphylococcus aureus--drug effects
Organophosphates--adverse effects
Oxazoles--adverse effects
Penicillanic Acid--adverse effects
Phenobarbital
Staphylococcal Infections--drug therapy
Tazobactam
Theophylline
Triazoles--adverse effects
Ceftaroline
[New antibiotics - standstill or progress]. [electronic resource] - Medizinische Klinik, Intensivmedizin und Notfallmedizin Apr 2017 - 206-213 p. digital
Publication Type: Comparative Study; Journal Article; Review
2193-6226
10.1007/s00063-017-0271-3 doi
Anti-Bacterial Agents--adverse effects
Azabicyclo Compounds--therapeutic use
Bacterial Infections--drug therapy
Ceftazidime--therapeutic use
Cephalosporins--adverse effects
Clinical Trials as Topic
Drug Approval
Drug Combinations
Drug Resistance, Multiple, Bacterial
Ephedrine
Humans
Macrolides--adverse effects
Methicillin-Resistant Staphylococcus aureus--drug effects
Organophosphates--adverse effects
Oxazoles--adverse effects
Penicillanic Acid--adverse effects
Phenobarbital
Staphylococcal Infections--drug therapy
Tazobactam
Theophylline
Triazoles--adverse effects
Ceftaroline